Search Results
Found 2 results
510(k) Data Aggregation
(202 days)
Monosyn Quick Synthetic Absorbable Surgical Suture is intended for general soft tissue approximation of the skin and mucosa, where only short term wound support (6-7 days) is required. Monosyn Quick suture is not indicated for use in cardiovascular or neurosurgery.
Monosyn Quick is an absorbable flexible monofilament suture which is supplied sterile. It is composed of a synthetic polyglycolic acid-based copolymer. The Monosyn Quick suture is undyed and will be offered in diameters ranging from USP size 6-0 through 1. It is uncoated and will be available in a variety of cut lengths with or with out needles attached.
The provided text describes the regulatory filing for a medical device, the Monosyn Quick Synthetic Absorbable Surgical Suture, and outlines the testing performed to demonstrate its substantial equivalence to predicate devices. However, the document does not detail a study proving the device meets "acceptance criteria" in the way one might expect for a diagnostic or AI-driven system. Instead, it focuses on demonstrating compliance with recognized standards and substantial equivalence to existing devices for safety and performance.
Therefore, many of the requested categories for acceptance criteria and study details are not directly applicable to this type of regulatory submission (510(k) for a surgical suture). I will answer the questions based on the closest available information in the document.
Here's a breakdown of the information that can be extracted:
1. A table of acceptance criteria and the reported device performance
The document doesn't explicitly state "acceptance criteria" as defined by specific thresholds for performance metrics. Instead, it refers to compliance with established USP standards for surgical sutures. The performance data is presented as satisfactory and demonstrating equivalence.
Acceptance Criteria Category | Reported Device Performance (Compliance) |
---|---|
USP 39 Monograph for Absorbable Surgical Sutures | Meets requirements |
USP 39 Sutures - Diameter | Meets requirements (with labeling for minimal deviation) |
USP 39 Tensile Strength | Meets requirements |
USP 39 Sutures - Needle Attachment | Meets requirements |
ISO 10993-1:2009 (Biocompatibility) | Compliance demonstrated |
ISO 10993-5 (In vitro cytotoxicity) | Compliance demonstrated |
ISO 10993-6 (Local Effects After Implantation) | Compliance demonstrated |
ISO 10993-7 (Ethylene oxide sterilization residuals) | Compliance demonstrated |
ISO 10993-10 (Irritation And Skin Sensitization) | Compliance demonstrated |
ISO 10993-11 (Systemic Toxicity) | Compliance demonstrated |
ISO 11135-1:2007 (EO Sterilization) | Compliance demonstrated |
Residual strength and absorption rate | Demonstrates substantial equivalence to predicate devices |
2. Sample size used for the test set and the data provenance
The document does not specify the sample sizes for the mechanical, biocompatibility, or resorption tests. It refers to "testing" and "data generation" but not specific numbers of samples. Data provenance is not mentioned beyond the tests being performed to support the 510(k) submission.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This concept is not applicable here. Surgical sutures are evaluated against engineering and biological standards, not through expert consensus on qualitative "ground truth" like in AI/diagnostic imaging.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. This type of adjudication is used for establishing ground truth in human-AI studies, not for the evaluation of a physical medical device like a suture.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a surgical suture, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is a surgical suture, not a standalone algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
The "ground truth" equivalent in this context is the adherence to established industry standards and regulations:
- USP (United States Pharmacopeia) 39 Monograph for Absorbable Surgical Sutures: Provides specifications for material, diameter, tensile strength, and other physical properties.
- ISO (International Organization for Standardization) 10993 series and 11135-1: Provide standards for biological evaluation (biocompatibility) and sterilization processes for medical devices.
- Predicate Device Performance: Comparison to existing legally marketed devices serves as a benchmark for safety and effectiveness.
8. The sample size for the training set
Not applicable. Medical devices like sutures are not "trained" in the machine learning sense. The manufacturing process is established and controlled, but there isn't a "training set" of data in the way an AI model would have one.
9. How the ground truth for the training set was established
Not applicable. As noted above, this device does not utilize machine learning or require a training set with established ground truth in that context.
Ask a specific question about this device
(148 days)
VisiPlugST provide temporary occlusion of the tear drainage system. VisiPlugST may be used as a diagnostic aid to determine the potential effectiveness of long-term occlusion, to temporarily enhance the efficacy of topical medication or ocular lubricants, after surgery to prevent complications due to dry eyes, to evaluate treatment of ocular dryness secondary to contact lens use, and to evaluate the dry eye component of ocular surface diseases (OSD).
The proposed device is an ophthalmic device commonly referred to as a punctum plug. It is designed to be placed by a practitioner into the horizontal canaliculus to restrict the natural lubricating tears from being pumped off the eye.
VisiPlugST provides temporary occlusion of the tear drainage system. The device may be used as a diagnostic aid to determine the potential effectiveness of long-term occlusion, to temporarily enhance the efficacy of topical medications or ocular lubricants, after surgery to prevent complications due to dry eyes, to evaluate treatment of ocular dryness secondary to contact lens use, and to evaluate the dry eye component of ocular surface diseases (OSD).
VisiPlugST plugs are cylindrical in shape, approximately 1.75-2.00mm in length, and available in three sizes: 0.3mm, 0.4mm and 0.5mm. Each plug is cut from a monofilament strand of Glycoprene® MG23, a synthetic surgical grade polymer composed of poly(glycolide-co-trimethylene carbonate-co-caprolactone). The monofilament is dyed with an approved color additive, Green D & C 6 (CAS# 128-80-3; 0.1% by weight). Titanium dioxide is added to the polymer to make the plugs opaque, providing a satisfactory means with which to determine the plug's presence or absence following insertion by a practitioner.
The VisiPlugST is a punctum plug designed for temporary occlusion of the tear drainage system.
1. Acceptance Criteria and Reported Device Performance
The acceptance criteria for the VisiPlugST were based on comparing its material properties to an existing predicate device (Collagen Plugs for the Lacrimal Efficiency Test, K895342) and referenced predicate devices (Maxon, Sterile Synthetic Absorbable Sutures K990951 and CaproSyn Suture K032586). The primary performance characteristics evaluated were strength retention and mass loss degradation rates.
Performance Metric | Predicate Device (Gut Suture) Performance | Acceptance Criteria (Implicit: Substantial Equivalence to Predicate) | Reported VisiPlugST Performance (Glycoprene® MG23) | Conclusion |
---|---|---|---|---|
Strength Retention Rate (at 3-5 days) | 40% strength retention at 3 days | Similar strength retention profile | 40% strength retention at 4-5 days | Meets |
Mass Loss Profile (at 30 days) | 45% mass loss | Similar mass loss profile | 46% mass loss | Meets |
Biocompatibility | Safe | Safe | Safe | Meets |
2. Sample Size and Data Provenance
The document does not explicitly state a separate "test set" and a "training set" in the context of an algorithm or image analysis. The data provided refers to nonclinical tests conducted to assess the material properties of the VisiPlugST (Glycoprene® MG23) against its predicate device (gut suture).
- Sample Size for Test Set: Not explicitly stated for each test, but studies were conducted to compare strength and mass loss degradation rates.
- Data Provenance: The studies were nonclinical tests comparing material properties. The country of origin and whether it was retrospective or prospective is not specified, but it refers to laboratory testing of materials.
3. Number of Experts and Qualifications for Ground Truth Establishment
This device is not an AI/ML device that requires expert review for ground truth establishment. The performance data is based on laboratory physical and chemical testing of the device material.
4. Adjudication Method for Test Set
Not applicable as this is not a diagnostic device requiring human reader adjudication.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
Not applicable. This is not an AI-assisted diagnostic device.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
Not applicable. This is a physical medical device, not an algorithm.
7. Type of Ground Truth Used
The "ground truth" for the nonclinical tests was established through laboratory measurements and scientific analysis of the material properties (strength retention, mass loss) and biocompatibility of the Glycoprene® MG23 material, compared against established values and properties of the predicate device's material (gut suture).
8. Sample Size for the Training Set
Not applicable, as this device does not involve a "training set" in the context of an algorithm.
9. How the Ground Truth for the Training Set Was Established
Not applicable.
Ask a specific question about this device
Page 1 of 1